Can-Fite BioPharma American Depositary Shares
CANF
4 hedge funds and large institutions have $50.7K invested in Can-Fite BioPharma American Depositary Shares in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
33% less funds holding
Funds holding: 6 → 4 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
77% less capital invested
Capital invested by funds: $225K → $50.7K (-$174K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$38.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$14.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$107K |
| 2 |
Morgan Stanley
New York
|
-$38.7K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13K |
| 4 |
AF
Advisornet Financial
Minnetonka,
Minnesota
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $26K | +$38.7K | +101 | New |
|
|
2
Morgan Stanley
New York
| $13K | -$38.7K | -101 | -66% |
|
|
3
UBS Group
Zurich,
Switzerland
| $11K | +$14.9K | +39 | +975% |
|
|
FDCDDQ
4
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $698 | – | – | – |
|
|
5
Renaissance Technologies
New York
| – | -$107K | -162 | Closed |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$13K | -20 | Closed |
|
|
AF
7
Advisornet Financial
Minnetonka,
Minnesota
| – | -$1K | -1 | Closed |
|
CANF Hedge Fund Activity: Q1 2020 in Review
4 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q1 2020, worth a combined $50.7K — down 77% from $225K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CANF and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $38.7K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $107K sold.
- 4 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q1 2020, down from 6 in Q4 2019.
- Funds reported $50.7K of Can-Fite BioPharma American Depositary Shares stock for Q1 2020, down 77% quarter-over-quarter.
- 1 fund opened new Can-Fite BioPharma American Depositary Shares positions in Q1 2020 and 3 closed out, a net change of -2 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q1 2020 was Citadel Advisors, an estimated $38.7K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q1 2020 was Renaissance Technologies, an estimated $107K sold.
Based on aggregated 13F filings for Q1 2020.